31.03.2014 Views

in vitro PHARMACOLOGY 2011 CATALOG - Cerep

in vitro PHARMACOLOGY 2011 CATALOG - Cerep

in vitro PHARMACOLOGY 2011 CATALOG - Cerep

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

86 <strong>in</strong> <strong>vitro</strong> pharmacology <strong>2011</strong> catalog<br />

❚ gaba<br />

Cl – channel (GABA-gated) - antagonist radioligand<br />

b<strong>in</strong>d<strong>in</strong>g<br />

Ref. 0170<br />

Q 3 weeks<br />

Included <strong>in</strong>:<br />

ExpresS Profile<br />

High-throughput profile<br />

Diversity profile<br />

BioPr<strong>in</strong>t ® profile<br />

Organ safety profile<br />

Source<br />

Ligand<br />

Kd<br />

Non specific<br />

Reference<br />

rat cerebral cortex<br />

[ 35 S]TBPS (3 nM)<br />

14.6 nM<br />

picrotox<strong>in</strong><strong>in</strong> (20 µM)<br />

picrotox<strong>in</strong><strong>in</strong> (IC 50 : 150 nM)<br />

Lew<strong>in</strong>, A.H. et al. (1989) Mol. Pharmacol., 35: 189-194.<br />

specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />

100<br />

50<br />

picrotox<strong>in</strong><strong>in</strong><br />

muscimol<br />

0<br />

GABA<br />

-9 -8 -7 -6 -5 -4<br />

log [drug] (M)<br />

❚ See other GABA assays pp. 38, 97 and 104<br />

❚ Glutamate<br />

AMPA - agonist radioligand<br />

b<strong>in</strong>d<strong>in</strong>g<br />

Ref. 0064<br />

Q 3 weeks<br />

Included <strong>in</strong>:<br />

Diversity profile<br />

BioPr<strong>in</strong>t ® profile<br />

Organ safety profile<br />

Source<br />

Ligand<br />

Kd<br />

Non specific<br />

Reference<br />

rat cerebral cortex<br />

[ 3 H]AMPA (8 nM)<br />

82 nM<br />

L-glutamate (1 mM)<br />

L-glutamate (IC 50 : 535 nM)<br />

Murphy, D.E. et al. (1987) Neurochem. Res., 12: 775-781.<br />

specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />

100<br />

50<br />

0<br />

-8 -7 -6 -5 -4<br />

log [drug] (M)<br />

L-glutamate<br />

ka<strong>in</strong>ic acid<br />

CGS 19755<br />

ka<strong>in</strong>ate - agonist radioligand<br />

b<strong>in</strong>d<strong>in</strong>g<br />

Ref. 0065<br />

Q 3 weeks<br />

Included <strong>in</strong>:<br />

Diversity profile<br />

BioPr<strong>in</strong>t ® profile<br />

Organ safety profile<br />

Source<br />

Ligand<br />

Kd<br />

Non specific<br />

Reference<br />

rat cerebral cortex<br />

[ 3 H]ka<strong>in</strong>ic acid (5 nM)<br />

19 nM<br />

L-glutamate (1 mM)<br />

ka<strong>in</strong>ic acid (IC 50 : 40 nM)<br />

Monaghan, D.T. and Cotman, C.W. (1982) Bra<strong>in</strong> Res., 252: 91-100.<br />

specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />

100<br />

50<br />

0<br />

-10 -9 -8 -7 -6 -5 -4<br />

log [drug] (M)<br />

ka<strong>in</strong>ic acid<br />

L-glutamate<br />

CGS 19755<br />

NMDA - antagonist radioligand<br />

b<strong>in</strong>d<strong>in</strong>g<br />

Ref. 0066<br />

Q 3 weeks<br />

Included <strong>in</strong>:<br />

Diversity profile<br />

BioPr<strong>in</strong>t ® profile<br />

Organ safety profile<br />

Source<br />

Ligand<br />

Kd<br />

Non specific<br />

Reference<br />

rat cerebral cortex<br />

[ 3 H]CGP 39653 (5 nM)<br />

23 nM<br />

L-glutamate (100 µM)<br />

CGS 19755 (IC 50 : 550 nM)<br />

Sills, M.A. et al. (1991) Eur. J. Pharmacol., 192: 19-24.<br />

specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />

100<br />

50<br />

CGS 19755<br />

L-glutamate<br />

0<br />

ka<strong>in</strong>ic acid<br />

-9 -8 -7 -6 -5 -4<br />

log [drug] (M)<br />

PCP - antagonist radioligand<br />

b<strong>in</strong>d<strong>in</strong>g<br />

Ref. 0124<br />

Q 3 weeks<br />

Included <strong>in</strong>:<br />

High-throughput profile<br />

Diversity profile<br />

BioPr<strong>in</strong>t ® profile<br />

Organ safety profile<br />

Source<br />

Ligand<br />

Kd<br />

Non specific<br />

Reference<br />

rat cerebral cortex<br />

[ 3 H]TCP (10 nM)<br />

13 nM<br />

MK 801 (10 µM)<br />

MK 801 (IC 50 : 5.3 nM)<br />

Vignon, J. et al. (1986) Bra<strong>in</strong> Res., 378: 133-141.<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

For further details and updated <strong>in</strong>formation on assays:<br />

❚ Please go to www.cerep.com catalog onl<strong>in</strong>e or contact us at sales@cerep.com<br />

❚ Europe: +33 (0)5 49 89 30 00 – USA: +1 (425) 895 8666 – Japan: +81 (0)3 3354 4026 – Ch<strong>in</strong>a: +86 21 5132 0568<br />

Assay developed <strong>in</strong> 2010 New assay conditions Human Q Standard turnaround time

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!